nach oben

International Ophthalmology

Erschienen in:

01.09.2022 | Original Paper

A novel homozygous ZNF469 variant causing brittle cornea syndrome is associated with corneal ectasias in heterozygous carriers

Erschienen in: International Ophthalmology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim

To describe a family segregating a novel truncating ZNF469 homozygous mutation causing brittle cornea syndrome type 1 in a male patient and associated with corneal ectasia in his two heterozygous young children.

Methods

A 49-year-old affected male and his 12- and 8-year-old, apparently healthy, siblings underwent phenotypic and genetic assessment. An Oculus Pentacam Scheimpflug topographer system was employed for keratometries and central corneal thickness measurements. Exome sequencing was performed in DNA from the index case with subsequent Sanger sequencing confirmation of the ZNF469 gene causal variant in his relatives.

Results

The index case had a history of bilateral keratoglobus, corneal perforations, bilateral hypoacusia, and skeletal anomalies. His two children exhibited topographic anomalies compatible with keratoconus suspects as well as mild skeletal anomalies. Genetic analysis identified a novel homozygous c.2340delC variant in the ZNF469 gene, which predicts a p.(Arg781Glufs*19) truncated protein. Sanger sequencing identified heterozygosity for the c.2340delC variant in DNA from both siblings.

Conclusion

Our results expand the mutational spectrum associated with brittle cornea syndrome and provide the first demonstration of early corneal anomalies in subjects carrying monoallelic ZNF469 variants.

Salomão MQ, Hofling-Lima AL, Gomes Esporcatte LP et al (2021) Ectatic diseases. Exp Eye Res 202:108347. https://doi.org/10.1016/j.exer.2020.108347CrossRefPubMed

Bertelsen TI (1968) Dysgenesis mesodermalis corneae et sclerae: rupture of both corneae in a patient with blue sclerae. Acta Ophthalmol 46:486–491CrossRef

Burkitt Wright EMM, Spencer HL, Daly SB et al (2011) Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance. Am J Hum Genet 88:767–777. https://doi.org/10.1016/j.ajhg.2011.05.007CrossRefPubMedPubMedCentral

Dhooge T, Van Damme T, Syx D et al (2021) More than meets the eye: expanding and reviewing the clinical and mutational spectrum of brittle cornea syndrome. Hum Mut 42:711–730. https://doi.org/10.1002/humu.24199CrossRefPubMed

Cameron JA (1993) Corneal abnormalities in Ehlers-Danlos syndrome type VI. Cornea 12:54–59. https://doi.org/10.1097/00003226-199301000-00009CrossRefPubMed

Abu A, Frydman M, Marek D et al (2008) Deleterious mutations in the zinc-finger 469 gene cause brittle cornea syndrome. Am J Hum Genet 82:1217–1222. https://doi.org/10.1016/j.ajhg.2008.04.001CrossRefPubMedPubMedCentral

Galli GG, Honnens de Lichtenberg K, Carrara M et al (2012) PRDM5 regulates collagen gene transcription by association with RNA polymerase II in developing bone. PLoS Genet 8:e1002711. https://doi.org/10.1371/journal.pgen.1002711CrossRefPubMedPubMedCentral

Khan AO (2010) Blue sclera with and without corneal fragility (brittle cornea syndrome) in a consanguineous family harboring znf469 mutation (p.E1392X). Arch Ophthalmol 128:1376. https://doi.org/10.1001/archophthalmol.2010.238CrossRefPubMed

Davidson AE, Borasio E, Liskova P et al (2015) Brittle cornea syndrome ZNF469 mutation carrier phenotype and segregation analysis of rare ZNF469 variants in Familial Keratoconus. Invest Ophthalmol Vis Sci 56:578–586. https://doi.org/10.1167/iovs.14-15792CrossRefPubMed

10.

Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and genomics and the Association for Molecular Pathology. Genet Med 17:405–423. https://doi.org/10.1038/gim.2015.30CrossRefPubMedPubMedCentral

11.

Rohrbach M, Spencer HL, Porter LF et al (2013) ZNF469 frequently mutated in the brittle cornea syndrome (BCS) is a single exon gene possibly regulating the expression of several extracellular matrix components. Mol Genet Metab 109:289–295. https://doi.org/10.1016/j.ymgme.2013.04.014CrossRefPubMedPubMedCentral

12.

Lu Y, Dimasi DP, Hysi PG et al (2010) Common genetic variants near the brittle cornea syndrome locus ZNF469 influence the blinding disease risk factor central corneal thickness. PLoS Genet 6:e1000947. https://doi.org/10.1371/journal.pgen.1000947CrossRefPubMedPubMedCentral

13.

Swierkowska J, Gajecka M (2017) Genetic factors influencing the reduction of central corneal thickness in disorders affecting the eye. Ophthalmic Genet 38:501–510. https://doi.org/10.1080/13816810.2017.131399CrossRefPubMed

14.

Eleiwa T, Raheem M, Patel NA et al (2020) Case series of brittle cornea syndrome. Case Rep Ophthalmol Med 20:4381273. https://doi.org/10.1155/2020/4381274CrossRef

15.

Tinkle BT (2021) Ehlers-Danlos syndrome. In: Carey JC, Battaglia A, Viskochil D, Cassidy SB (eds) Cassidy and allanson’s management of genetic syndromes, 4th edn. Wiley, New York, pp 389–403CrossRef

16.

Micheal S, Siddiqui S, Zafar N et al (2019) Identification of a novel ZNF469 mutation in a Pakistani family with brittle cornea syndrome. Cornea 38:718–722. https://doi.org/10.1097/ico.0000000000001828CrossRefPubMed

17.

Klyce SD (2009) Chasing the suspect: keratoconus. Br J Ophthalmol 93:845–847. https://doi.org/10.1136/bjo.2008.147371CrossRefPubMed

18.

Cundy T, Vincent A, Robertson S (2021) Does brittle cornea syndrome have a bone fragility phenotype? Bone Rep 15:101124. https://doi.org/10.1016/j.bonr.2021.101124CrossRefPubMedPubMedCentral

19.

Tibbe D, Tim VD, Syx D et al (2021) More than meets the eye: expanding and reviewing the clinical and mutational spectrum of brittle cornea syndrome. Hum Mutat 42:711–730. https://doi.org/10.1002/humu.24199CrossRefPubMed

20.

Rolvien T, Kornak U, Linke S, Amling M, Ohelm R (2020) Whole-exome sequencing identifies novel compound heterozygous ZNF469 mutations in two siblings with mild brittle cornea syndrome. Calcif Tissue Int 107:294–299. https://doi.org/10.1007/s00223-020-00721-3CrossRefPubMedPubMedCentral

21.

Skalicka P, Porter L, Brejchova K, Malinka F, Durdakova L, Liskova P (2020) Brittle cornea syndrome: disease-causing mutations in ZNF469 and two novel variants identified in a patient followed for 26 years. Biomed Pap Med Fac Univ Palcky Olomouc Czech Repub 164:183–188. https://doi.org/10.5507/bp.2019.017CrossRef

22.

Micheal S, Noorani S, Nuzhat S et al (2019) Identification of a Novel ZNF469 mutation ina Pakistani family with brittle cornea syndrome. Cornea 38:718–722. https://doi.org/10.1097/ICO.0000000000001828CrossRefPubMed

23.

Menzel-Severing J, Meiler R, Kraus C, Trollman R, Atalay D (2019) Brittle cornea syndrome type 1 caused by compound heterozygosity of two mutations in the ZNF469 gene. Ofthalmologe 116:780–784. https://doi.org/10.1007/s00347-018-0796-8CrossRef

24.

Rohrbach M, Spencer H, Porter L et al (2013) ZNF469 frequently mutated in the brittle cornea syndrome (BCS) is a single exon gene posssibly regulating the expression of several extracellular matrix components. Mol Genet Metab 109:289–295. https://doi.org/10.1016/j.ymgme.2013.04.014CrossRefPubMedPubMedCentral

25.

Al-Hussain H, Zeisberg S, Huber P, Glunta C, Steinmann B (2004) Brittle cornea syndrome and its delineation from the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI): report on 23 patients and review of the literature. Am J Med Genet A 124A:28–34. https://doi.org/10.1002/ajmg.a.20326CrossRefPubMed

26.

Khan AO, Aldahmesh M, Alkuraya F (2012) Brittle cornea without clinically-evident extraocular findings in an adult harboring a novel homozygous ZNF469 mutation. Ophthalmic Genet 33:257–259. https://doi.org/10.3109/13816810.2012.670362CrossRefPubMed

27.

Al-Owain M, Al-dosari M, Sunker A, Shuaib T, Alkuraya F (2012) Identification of a novel ZNF469 mutation in a large family with Ehlers-Danlos phenotype. Gene 511:447–450. https://doi.org/10.1016/j.gene.2012.09.022CrossRefPubMed

28.

Khan AO, Aldahmesh M, Mohamed JN (2010) Blue sclera with and withour corneal fragility (brittle cornea syndrome) in a consanguineous family Harboring ZNF469 mutation (p. E1392X). Arch Ophthalmol 128:1376–1379. https://doi.org/10.1001/archophthalmol.2010.238CrossRefPubMed

29.

Abu A, Frydman M, Marek D et al (2006) Mapping of a gene causing brittle cornea syndrome in Tunisan jews to 16q24. Invest Ophtalmol Vis Sci 47:5283–5287. https://doi.org/10.1167/iovs.06-0206CrossRef

Titel: A novel homozygous ZNF469 variant causing brittle cornea syndrome is associated with corneal ectasias in heterozygous carriers
Publikationsdatum: 01.09.2022
Erschienen in: International Ophthalmology / Ausgabe 3/2023
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-022-02481-5

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

A novel homozygous ZNF469 variant causing brittle cornea syndrome is associated with corneal ectasias in heterozygous carriers

Abstract

Aim

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2023

Analysis of Demodex infection rate and risk factors in patients with meibomian gland dysfunction

Long-term outcomes of adjustable strabismus surgery at a Pakistani university hospital

Epidemiology and clinical characteristics of psoriatic arthritis-related uveitis in Madrid, Spain

A relatively low glucose promotes the proliferation of vascular endothelial cells by suppressing VEGFR2 O-GlcNAcylation and its proteasome degradation

Ocular pulse amplitude and visual field changes in patients diagnosed with aortic regurgitation

Epidemiology of United States tennis-related ocular injuries from 2000 to 2019

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde